PMID: 2505199Jul 3, 1989Paper

Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP

Neuroscience Letters
S RoseC D Marsden

Abstract

Administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to common marmosets initially impaired motor function, but a partial recovery occurred over the following weeks. At both 10 days and 4-6 weeks following MPTP treatment, [3H]dopamine ([3H]DA) uptake into synaptosomal preparations of putamen was markedly decreased. At 10 days and 4-6 weeks following MPTP treatment DA, homovanillic acid (HVA) and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the caudate nucleus and nucleus accumbens were substantially reduced. However, the levels of HVA and DOPAC in caudate nucleus were higher at 4-6 weeks than at 10 days. The ratio of (DOPAC + HVA)/DA in caudate nucleus was elevated at 10 days following MPTP treatment and even more so at 4-6 weeks. No change in Bmax or Kd values for [3H]spiperone binding to caudate preparations were observed. The recovery of motor function in marmosets observed following MPTP treatment may result partially from a compensatory increase in caudate DA turnover by remaining neurones.

References


❮ Previous
Next ❯

Citations

Oct 3, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Lance A SmithPeter Jenner
Jan 1, 1995·Journal of Neural Transmission. General Section·K K GnanalinghamC D Marsden
Jan 1, 1989·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·M ZreikaM G Palfreyman
Jan 12, 1993·European Journal of Pharmacology·S RoseC D Marsden
Aug 31, 2006·Behavioural Pharmacology·Sanneke A M van VlietIngrid H C H M Philippens
Dec 18, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·R E YeeJ R Barrio
Jan 1, 1993·Experimental Brain Research·P GasparJ Colombo
May 16, 2006·Neurochemistry International·Christian Pifl, Oleh Hornykiewicz
Dec 23, 2008·Neurobiology of Aging·Abdelmojib Al-WandiVladimir L Buchman
Oct 16, 2010·Journal of Pharmacological Sciences·Mohammed Emamussalehin ChoudhuryMasahiro Nomoto
May 1, 2009·Journal of Pharmacological Sciences·Hayato YabeMasahiro Nomoto
Feb 24, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Michelle PorrittDavid Howells
Apr 19, 2007·Brain : a Journal of Neurology·W San SebastiánM R Luquin
Jun 16, 2014·Animal Cognition·Todd M FreebergCecilia Kullberg
Apr 14, 2011·British Journal of Pharmacology·Susan Duty, Peter Jenner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.